Role of Helicobacter pylori and autoimmunity in serological atrophic corpus gastritis in a Dutch primary care community

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 8, 2006, Pages 911-916

  Korstanje, André ^d   Den Hartog, Gijsbert ^a   Biemond, Izak ^b   Roelandse, Freek W C ^c   Souverijn, John H M ^c   Lamers, Cornelis B H W ^b,c  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b University Medical Centre   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NONE

Author keywords

Gastrin; Helicobacter pylori infection; Parietal cell antibodies; Pepsinogen; Primary care community; Serological atrophic corpus gastritis

Indexed keywords

ANTIBODY; BACTERIUM ANTIBODY; BIOLOGICAL MARKER; GASTRIN; PEPSINOGEN; PEPSINOGEN II;

ADULT; AGED; ARTICLE; ATROPIC CORPUS GASTRITIS; AUTOIMMUNITY; BACTERIAL VIRULENCE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOASSAY; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SEROPREVALENCE; STOMACH CANCER; STOMACH PARIETAL CELL; WESTERN EUROPE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; AUTOIMMUNITY; CASE-CONTROL STUDIES; FEMALE; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PARIETAL CELLS, GASTRIC; PEPSINOGENS; PRIMARY HEALTH CARE; SEROEPIDEMIOLOGIC STUDIES;

EID: 33745901080     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200608000-00018     Document Type: Article

References (43)

1. Kapadia CR. Gastric atrophy, metaplasia and dysplasia. A clinical perspective. J Clin Gastroenterol 2003; 36 (suppl 1):29-36.
2. Genta RM. The gastritis connection. Prevention and early detection of gastric neoplasms. J Clin Gastroenterol 2003; 36 (suppl 1):44-49.
3. Sun J, Misumi J, Shimaoka A, Aoki K, Esaki F. Stomach cancer-related mortality. Eur J Cancer Prev 2001; 10:61-67.
4. Stemmermann GN, Fenoglio-Preiser C. Gastric carcinoma distal to the cardia: a review of the epidemiological pathology of the precursors to a preventable cancer. Pathology 2002; 34:494-503.
5. Palli D. Epidemiology of gastric cancer: an evaluation of available evidence. J Gastroenterol 2000; 35 (suppl 12):84-89.
6. Lam SK. 9th Seah Cheng Siang Memorial Lecture: gastric-cancer - where are we now? Ann Acad Med Singapore 1999; 28:881-889.
7. Lahey RJF, Jansen JBMJ, Lisdonk vd EH, Severens JL, Verbeek ALM. The prognostic value of gastrointestinal morbidity for gastric cancer. Family Practice 1999; 16:129-132.
8. Ley C, Mohar A, Guarner J, HerreraGoepfert R, Figueroa LS, Halperin D, et al. Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol Biomarkers Prev 2001; 10:107-112.
9. Morrison AS. Screening in chronic disease: Monographs in epidemiology and biostatistics. Vol. 7. New York: Oxford University Press; 1985.
10. Korstanje A, Hartog G, den Biemond I, Lamers CBHW. The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient. Scand J Gastroenterol Suppl 2002; 236:22-26.
11. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83:204-209.
12. Westerveld BD, Pals G, Lamers CB, Defize J, Pronk JC, Frants RR, et al. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels and serum gastrin levels. Cancer 1987; 59:952-958.
13. Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen MD, Ledin T, Szesci PB. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 1989: 24:870-876.
14. Kekki M, Samloff IM, Varis K, Ihamaki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic gastritis. Scand J Gastroenterol 1991; 26:109-116.
15. Kitahara F, Kobayashi K, Sato T, Kojima Y, Arabki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999; 44:693-697.
16. Kodoi A, Yoshihara M, Sumii K, Haruma K, Kajiyama G. Serum pepsinogen in screening for gastric cancer. J Gastroenterol 1995; 30:452-460.
17. Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 1996; 91:959-962.
18. Ito M, Haruma S, Kaya S, Kamada T, Kim S, Sasaki A, et al. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: evaluation in a country of high prevalence of atrophic gastritis. Scand J Gastroenterol 2002; 3:287-293.
19. Whittingham S, Mackay IR. Autoimmune gastritis: historical antecedents, outstanding discoveries, and unresolved problems. Int Rev Immunol 2005; 24:1-29.
20. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-1131.
21. Eurogast study group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341:1359-1362.
22. Kuipers EJ, Meuwissen SG. Helicobacter pylori and gastric carcinogenesis. Scand J Gastroenterol Suppl 1996; 218:103-105.
23. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-789.
24. Yaron N. Family history of gastric cancer. Should we test and treat for Helicobacter pylori? J Clin Gastroenterol 2003; 36:204-208.
25. Biemond I, Jansen JBMJ, Crobach LFSJ, Kreuning J, Lamers CB. Radioimmunoassay of human pepsinogen A and pepsinogen C. J Clin Chem Clin Biochem 1989; 27:19-25.
26. Peňa AS, Endtz HPh, Offerhaus GJ, Hoogenboom-Verdegaal A, van Duijn W, de Vargas N, et al. Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion 1989; 44:131-141.
27. Biemond I, Kreuning J, Jansen JBMJ, Lamers CBHW. Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. Gut 1993; 34:1315-1318.
28. Steenland K, Deddens J. Increased precision using countermatching in nested case-control studies. Epidemiology 1997; 8:238-242.
29. Ernster VL. Nested case-control studies. Prev Med 1994; 23:587-590.
30. Armitage P, editor. Relative risk. In: Statistical methods in medical research. Oxford: Blackwell Scientific Publications; 1971, pp. 427-433.
31. Pereira Gray DJ. Onderzoek in de huisartsgeneeskunde, de rol van academische netwerken. Huisarts Wetenschap 2002; 45:459-462.
32. Annibale B, Negrini R, Caruna P, Lahner E, Grossi C, Bordi C, et al. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter infection. Helicobacter 2001; 6:225-233.
33. Bins M, Burgers P, Selbach S, van Wettum TB, Lamers CB, van Tongeren JH. Prevalence of achlorhydria in a normal population and its relation to serum gastrin. Hepatogastroenterology 1984; 31:41-43.
34. Whitaker CJ, Dubiel AJ, Galpin OP. Social and geographical risk factors in . Helicobacter pylori infection. Epidemiol Infect 1993; 111:63-70.
35. Malaty H, El-Kasabany A, Graham DY, Miller CC, Reddy SG, Srinivasan SR, et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 2002; 359:931-935.
36. Tindberg Y, Bengtsson C, Granath F, Blennow M, Nyren O, Granstrom M. Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology 2001; 121:310-316.
37. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res 1992; 52:6735-6740.
38. Kokkola A, Kosunen TU, Puolakkainen P, Sipponen P, Harkonen M, Laxen F, et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic gastritis. APMIS 2003; 111:619-624.
39. Valle J, Kekki M, Sipponen P, Ihamaki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996; 31:546-550.
40. Faller G, Steininger H, Kranzlein J, Maul H, Kerkau T, Hensen J, et al. Antigastric autoantibodies in Helicobacter infection: implications of histological and clinical parameters of gastritis. Gut 1997; 41: 619-623.
41. Negrini R, Savio A, Appelmelk BJ. Autoantibodies to gastric mucosa in Helicobacter pylori infection. Helicobacter 1997; 2 (suppl 1):13-16.
42. Faller G, Ruff S, Reiche N, Hochberger J, Hahn EG, Kirchner Th. Mucosal production of antigastric autoantibodies in Helicobacter pylori gastritis. Helicobacter 2000; 5:129-135.
43. Sörberg M, Engstrand L, Ström M, Jönsson K-Å, Jorbeck H, Granstrom M. The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori. Scand J Infect Dis 1997; 29:147-151.